All Publications by Year

1995 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009

1995

Newman B, Moorman PG, Millikan. R, Qaqish BF, Geradts J, Aldrich TE, Lui ET. The Carolina Breast Cancer Study: Integrating population-based epidemiology and molecular biology. Breast Cancer Research and Treatment 35: 51-60, 1995. Abstract

Millikan R, DeVoto E, Newman B, Savitz D. Studying environment influences and breast cancer risk: Suggestions for an integrated population-based approach. Breast Cancer Research and Treatment 35: 70-89, 1995. Abstract

1998

Rockhill B, Newman B, Weinberg C. Uses and abuses of population attributable fraction. American Journal of Public Health 88: 15-19, 1998. PDF

Newman B, Mu H, Butler LM, Millikan RC, Moorman PG, King M-C. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 279: 915-921, 1998.Abstract PDF

Millikan RC, Pittman GS, Newman B, Tse C-KJ, Selmin O, Rockhill B, Savitz D, Moorman PG, Bell DA. Cigarette smoking, N-acetyltransferases 1 and 2 and breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention 7: 826-833, 1998. Abstract PDF

Rockhill B, Moorman PG, Newman B. Age at menarche, time to regular cycling, and risk of breast cancer. Cancer Causes and Control: 447-53, 1998.Abstract

Millikan RC, Pittman GS, Tse CKJ, Duell E, Newman B, Savitz D, Moorman PG, Boissy RJ, Bell DA. Catechol-O-methyltransferase (COMT) and breast cancer risk. Carcinogenesis 19: 1943-47, 1998. Abstract PDF

1999

Li Y, Millikan R, Tse C-KJ, Newman B, Conway K, Liu ET. Germline P57 polymorphisms and risk of breast cancer. Human Genetics 104: 83-88, 1999. Abstract

Furberg H, Newman B, Moorman P, Millikan R. Lactation and breast cancer risk. International Journal of Epidemiology 28: 396-402, 1999. Abstract PDF

Marcus P, Baird D, Millikan R, Moorman P, Qaqish B, Newman B. Adolescent reproductive events and subsequent breast cancer risk. American Journal of Public Health 89: 1244-47, 1999. Abstract PDF

Marcus P, Newman B, Moorman B, Millikan R, Baird D, Qaqish B, Sternfeld B. Physical activity at age 12 and adult breast cancer risk (United States). Cancer Causes and Control: 10(4): 293-302, 1999. Abstract

Schildkraut J, Demark-Wahnefried DeVoto E, Hughes C, Laseter J, Newman B. Environmental contaminants and body fat distribution. Cancer Epidemiology, Biomarkers and Prevention 8: 179-83, 1999. Abstract PDF

2000

Marcus P, Newman B, Moorman P, Millikan R, Baird D, Qaqish B. The associations of adolescent cigarette smoking, alcoholic beverage consumption and environmental tobacco smoke, and ionizing radiation with subsequent breast cancer risk (United States). Cancer Causes and Control 151(7) 703-14, 2000. Abstract

Kinney AY, Millikan RC, Lin YH, Moorman PG, Newman B. Alcohol consumption and breast cancer among black and white women in North Carolina. Cancer Causes and Control (Netherlands) 11(4): 345-357, 2000. Abstract

Huang W-Y, Newman B, Millikan R, Schell M, Hulka B, Moorman P. Hormone-related factors and risk of breast cancer by estrogen receptor and progesterone receptor status. American Journal of Epidemiology (US) 151(7): 703-714, 2000. Abstract PDF

Huang W-Y, Newman B, Millikan R, Conway K, Hulka B, Schell M, Liu E. Risk of breast cancer according to the status of Her-2/neu oncogene amplification. Cancer Epidemiology, Biomarkers and Prevention (US) 9(1): 65-71, 2000. Abstract PDF

Guillemette C, Millikan R, Newman B, Housman D. Genetic Polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African-Americans. Cancer Research 60(4): 950-6, 2000. Abstract PDF

Millikan RC. NAT1*10 and NAT1*11 polymorphisms and breast cancer risk. Cancer Epidemiology, Biomarkers, and Prevention 9(2): 217-9, 2000. Abstract PDF

Duell E, Millikan R, Savitz D, Newman B, Smith J, Schell M, Sandler D. A population-based case control study of farming and breast cancer in North Carolina. Epidemiology 11(5): 523-531, 2000. Abstract PDF

Moorman P, Kuwabara H, Millikan R, Newman B. Menopausal hormones and breast cancer in a biracial population. American Journal of Public Health 90(6): 966-971. Abstract PDF

Hall IJ, Newman B, Millikan R, Moorman P. Body size and breast cancer risk in black women and white women. American Journal of Epidemiology 151(8): 754-764, 2000. Abstract PDF

Duell E, Millikan R, Pittman G, Winkel S, Lunn R, Tse C-K, Eaton A, Mohrenweiser H, Newman B, Bell D. XRCC1 polymorphisms and breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention 10: 567-573, 2000. Abstract PDF

Millikan R, Pittman G, Tse C-K, Savitz D, Newman B, Bell D. Glutathione S-transferases M1, T1, and P1 and breast cancer. Cancer Epidemiology, Biomarkers and Prevention 9(6): 567- 573, 2000. Abstract PDF

Dunmore C, Plummer P, Regan G, Mattingly D, Jackson S, Millikan R. Re: Race and differences in breast cancer survival in a managed care population. Journal of National Cancer Institute 92: 1690-91, 2000. Abstract PDF

2001

Duell E, Millikan R, Savitz D, Schell M, Newman B, Tse C-K, Sandler D. Reliability of reported farming activities and pesticide use in a case-control study of breast cancer in North Carolina. Annals of Epidemiology 11: 178-85, 2001. Abstract

Moorman P, Jones B, Millikan R, Hall I, Newman B. Race, Anthropometric Factors and Stage at Diagnosis of Breast Cancer. American Journal of Epidemiology 153: 284-91, 2001. Abstract PDF

Tseng M, Yeatts K, Millikan R, Newman B. Area-level characteristics and smoking in women. American Journal of Public Health 91. 1847-50 (2001). Abstract PDF

Millikan R, DeVoto E, Duell E, Tse C-K, Savitz D, Beach J, Edmiston S, Jackson S, Newman B. DDEs, PCBs, and breast cancer: a case-control study of African-American and white women. Cancer Epidemiology, Biomarkers and Prevention 9: 567-73, 2001. Abstract PDF

Furberg H, Millikan R, Dressler L, Newman B, Geradts J. Tumor characteristics in African American and white women. Breast Cancer Research and Treatment 68: 33-43 2001. Abstract

Moorman P, Ricciuti M, Millikan R, Newman B. Vitamin and mineral supplements and breast cancer risk. Results from the Carolina Breast Cancer Study. Public Health and Nutrition 4: 821, 2001. Abstract PDF

Van Wijngaarden E, Nylander-French L, Millikan R, Savitz D, Loomis D. Population-based case-control study of occupational exposure to electromagnetic fields and female breast cancer. Annals of Epidemiology 11: 297-303. 2001. Abstract

Moorman P, Millikan R, Newman B. Oral contraceptives and breast cancer among African-American women and white women. Journal of the National Medical Association. 9: 329-34 (2001). Abstract PDF

2002

Conway K, Edmiston S, Cui L, Drouin S, Pang J, He M, Tse C-K, Geradts J, Dressler L, Liu E, Millikan R, Newman B. Prevalence and spectrum of p53 mutations associated with smoking in breast cancer. Cancer Research 62: 1987-95, 2002. Abstract PDF

Cooper G, Savitz D, Millikan R, Tse C-K. Organochlorine exposure and age at natural menopause. Epidemiology 13: 729-33, 2002. Abstract

Furberg H, Millikan RC, Geradts J, Gammon MD, Dressler LG, Ambrosone CB, Newman B. Environmental Factors in Relation to Breast Cancer Characterized by p53 Protein Expression. Cancer Epidemiology, Biomarkers and Prevention 11: 829-35, 2002. Abstract PDF

2003

Moorman P, Grubber J, Millikan RC, Newman B. Anti-depressant medications and their association with invasive breast cancer and carcinoma in situ of the breast. Epidemiology 14: 307-14, 2003. Abstract

Millikan R, Eaton A, Worley K, Biscocho L, Hodgson E, Huang W-Y, Geradts J, Iacocca M, Cowan D, Conway K, Dressler L. HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites. Breast Cancer Research and Treatment 79: 355-64, 2003. Abstract

Furberg H, Millikan RC, Geradts J, Gammon MD, Dressler LG, Ambrosone CB, Newman B. Reproductive factors in relation to breast cancer characterized by p53 protein expression (US). Cancer Causes and Control. 14: 609-18, 2003. Abstract

Moorman P, Grubber J, Millikan R, Newman B. Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast. Cancer Causes and Control 14: 915-922, 2003. Abstract

2004

Millikan R, Player J, de Cotret AR, Moorman P, Pittman G, Vannappagari V, Tse C-K, Keku T. Manganese Superoxide Dismutase (MnSOD) Ala-9Val polymorphism and risk of breast cancer in a population-based case-control study of African Americans and whites. Breast Cancer Research 6: 264-274, 2004. Abstract PDF

Li Y, Millikan R, Bell D, Cui L, Tse C-K, Newman B, Conway K. Cigarette smoking, cytochrome P4501A1 (CYP1A1) polymorphisms, and breast cancer among African Americans and white women. Breast Cancer Research 6: 460-473, 2004. Abstract PDF

Moorman P. Associations of aspirin use and hormone receptor status with breast cancer risk. Journal of the American Medical Association. 292: 1426, 2004. Excerpt

2005

Hall I, Moorman P, Millikan R, and Newman B.. Comparative analysis of breast cancer risk factors among African-American women and white women. American Journal of Epidemiology 161: 40-51, 2005. Abstract PDF

Millikan R, Hummer A, Wolff M, Begg C. HER2 codon 655 polymorphism and breast cancer: Results from kin-cohort and case-control analyses. Breast Cancer Research and Treatment. 89: 309-12, 2005. Abstract

Conway K, Parrish E, Edmiston S, Tolbert D, Tse J, Geradts J, Livasy C, Singh H, Newman B, Millikan R. The estrogen receptor alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population based study. Breast Cancer Research 7: R871-880, 2005. PDF

Canter J, Kallianpur A, Parl F, Millikan R. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Research 65: 8028-33, 2005. Abstract PDF

Lark A, Livasy C, Millikan R, Tse C-K, Moore D, Cowan D, Dressler L, Little D, Craven R, Cancer W. High FAK expression in invasive breast carcinomas is associated with aggressive phenotype. Modern Pathology 18: 1289-94, 2005. Abstract PDF

Millikan R, Player J, deCotret A, Tse C-K, Keku T. Polymorphisms in DNA repair genes, medical exposure to ionizing radiation and breast cancer risk. Cancer Epidemiology, Biomarkers and Prevention 14: 2326-34, 2005. Abstract PDF

Lin D, Zeng D, Millikan R. Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. Genetic Epidemiology, 29: 299-312, 2005. Abstract

Moorman P, Sesay J, Nwosu V, Kane J, de Cotret A, Worley K, Millikan R. COXR Polymorphism (Val511Ala), NSAID Use and Breast Cancer in African-American Women. Cancer Epidemiology, Biomarkers and Prevention 14: 3013-14, 2005.Abstract PDF

2006

Carey L, Perou C, Livasy C, Dressler L, Cowan D, Conway K, Karaca G, Troester M, Tse C-K, Edmiston S, Deming S, Geradts J, Cheang M, Nielson T, Moorman P, Earp H, Millikan R. Race, Breast Cancer Subtypes and Survival in the Carolina Breast Cancer Study. Journal of the American Medical Association 295: 2492-2502, 2006. Abstract PDF

Mechanic L, Millikan R, Player J, Rene de Cotret A, Winkel S, Worley K, Heard K, Tse C-K, Keku T. Polymorphisms in Nucleotide Excision Repair Genes, Smoking and Breast Cancer in African Americans and Whites: A Population-Based Case-Control Study. Carcinogenesis 27: 1377-85, 2006. Abstract PDF

Pachkowski B, Winkel S, Kubota Y, Swenberg J, Millikan R, Nakamura J. XRCC1 genotype and breast cancer: Functional studies and epidemiologic data demonstrate interactions between XRCC1 codon 280 His and smoking. Cancer Research 66: 2876-77, 2006. Abstract PDF

Millikan R, Heard K, Winkel S, Hill E, Heard K, Massa B, Mayes L, Williams P, Holston R, Conway K, Edmiston S, De Cotret AR. No association between the MDM2-309 T/G promoter polymorphism and breast cancer in African Americans or whites. Cancer Epidemiology, Biomarkers and Prevention 15: 175-77, 2006. Abstract PDF

2007

Livasy C, Perou C, Karaca G, Cowan D, Maria D, Jackson S, Tse C-K, Millikan RC. Identification of a basal-like subtype of breast ductal carcinoma in situ. Human Pathology. 38:197-204, 2007. Abstract

Conway K, Parrish E, Edmiston S, Tolbert D, Tse C-K, Moorman P, Newman B, Millikan R. Risk Factors for Breast Cancer Characterized by the Estrogen Receptor Alpha A908G (K303R) Mutation. Breast Cancer Research 9: R36, 2007. PDF

2008

Millikan R, Newman B, Tse C-K, Moorman P, Conway K, Smith L, Labbok M, Geradts J, Bensen, Jackson S, Nyante S, Livasy C, Carey L, Earp H, Perou Epidemiology of basal-like breast cancer. Breast Cancer Research and Treatment 190: 123-139, 2008 Abstract

dos Santos Silva I, DeStavola B, McCormack V. Collaborative Group on Pre-Natal Risk Factors and Subsequent Risk of Breast Cancer. Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies. PLoS Med. 5(9): e193, 2008 Abstract PDF

2009

Thorner A, Hoadley K, Parker J, Winkel S, Millikan R, and Perou C. In vitro and in vivo analysis of B-Myb in basal-like breast cancer Oncogene 28: 742-51, 2009 Abstract PDF

Phillips L, Millikan R, Shroeder J, Rockhill B, Barnholtz-Sloan J. Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast. Cancer Epidemiology, Biomarkers and Prevention. 18. 1507-14, 2009. Abstract

Return to Top